The global Retinal Disorder Treatment market size is expected to be worth around US$ 15.10 billion by 2028, according to a new report by Vision Research Reports.
The global Retinal Disorder Treatment market size was valued at US$ 8.10 billion in 2020 and is anticipated to grow at a CAGR of 7.10% during forecast period 2021 to 2028.
According to data published in the NCBI in 2018, around 18.0% of diabetic patients in India suffer from diabetic retinopathy. Similarly, National Eye Institute estimates that by 2030 and 2050, around 10 and 14 million people respectively will suffer from diabetic retinopathy in America. Based on an article published by WebMD in 2019, age-related macular degeneration (AMD) is the leading cause of irreversible visual loss in U.S., occurring in more than 10% of the population aged 65-74 years. Moreover, the NCBI estimates that by 2040, individuals with early and late AMD will range between 14.9-21.5 million and 3.9-4.8 million respectively in Europe.
Increasing geriatric population is also anticipated to be a major factor governing the overall market. According to data published in the World Population Prospects: 2019 Revision, around 1 in 11 and 1 in 4 people living in North America and Europe, respectively, will be aged 65 years and above by 2050.
Based on the type of retinal disorder, the market has been classified into macular degeneration, diabetic retinopathy, and others. Macular degeneration is further segmented into dry macular degeneration and wet macular degeneration.
macular degeneration dominated the market and is estimated to be the fastest-growing segment over the forecast period. New product launches for the treatment of macular degeneration is considered to be one of the major factors driving the segment growth. Also, increasing awareness of this form of the retinal disorder is expected to propel market growth over the forecast period. For instance, in February 2019, Bausch & Lomb Incorporated announced the availability of a new educational online resource, SightMatters.com, for people with age-related macular degeneration. According to estimates by the International Agency for the Prevention of Blindness, by 2020, around 196 million people will be affected by AMD globally.
Based on dosage form, the retinal disorder treatment market is segmented into gels, eye solutions, capsules and tablets, eye drops, and ointments. Eye solution emerged as the largest dosage form segment in 2020. The presence of various eye injections such as Lucentis and EYLEA for the treatment of retinal disorders is expected to drive segment growth. The eye drops segment is estimated to exhibit the fastest growth over the forecast period. Cost-effectiveness and rising initiatives to develop novel eye drops to treat AMD are some of the key factors responsible for its growth. For instance, PanOptica is developing PAN-90806, a novel topically applied eye drop for the treatment of wet AMD, and is currently under phase 2/3 clinical trials.
Based on the distribution channel, the overall market for retinal disorder treatment has been segmented into hospital pharmacy, retail pharmacy, and online pharmacy. Hospital pharmacy held the largest share in 2018 and is expected to retain its lead throughout the forecast period. Hospitals provide quality treatment and care to a large number of patients. Apart from this, improving healthcare plans and reimbursement policies are driving this segment. The segment is also fueled by growing investments in healthcare infrastructure in developing and underdeveloped economies.
Online pharmacy is estimated to be the fastest-growing segment over the forecast period. Increasing awareness among patients of retinal disorders about the benefits of online pharmacies such as lower prices, convenience, and expert advice and guidance is considered to be a major growth driving factor. According to a survey conducted by the Alliance for Safe Online Pharmacies Global in 2017, 33.0% of survey participants purchased prescription medicines from an online pharmacy in the U.S.
Santen Pharmaceutical Co., Ltd.; REGENERON; Graybug Vision, Inc.; Shire (Takeda Pharmaceuticals); Bayer AG; Genentech, Inc.; Acucela Inc.; and Pfizer Inc.
Dry Macular Degeneration
Wet Macular Degeneration
Dosage Form Outlook
Capsules & Tablets
Distribution Channel Outlook
Middle East & Africa
The Retinal Disorder Treatment market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Retinal Disorder Treatment market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Retinal Disorder Treatment market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Retinal Disorder Treatment market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Retinal Disorder Treatment market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Retinal Disorder Treatment capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Retinal Disorder Treatment by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Retinal Disorder Treatment market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2028. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Retinal Disorder Treatment market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Retinal Disorder Treatment market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Retinal Disorder Treatment industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Retinal Disorder Treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Retinal Disorder Treatment market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Retinal Disorder Treatment market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Retinal Disorder Treatment market. These factors have benefited the growth of the global market for Retinal Disorder Treatment. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Retinal Disorder Treatment. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Retinal Disorder Treatment are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
To strategically profile the key players and comprehensively analyze their growth strategies.
Cancer Immunotherapy Market (By Product: Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies and Cancer Vaccines; By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Ovarian Cancer, Pancreatic Cancer) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Women’s Health App Market (By Type: Fitness & Nutrition, Menstrual Health, Pregnancy Tracking & Postpartum Care, Menopause, Disease Management) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Biopharmaceutical Third Party Logistics Market (By Supply Chain: Cold Chain, Non-cold Chain; By Service Type: Transportation, Warehousing and Storage) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Traumatic Brain Injury Assessment & Management Devices Market (By Device: Imaging Devices, Monitoring Devices; By Technique: Intracranial Pressure (ICP) Monitoring, Partial Pressure of Oxygen in Brain Tissue (pBrO2); By End-use: Hospitals, Diagnostic Centers, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Magnetic Resonance Imaging Market (By Architecture: Closed System, Open System; By Field Strength: Low Field Strength, Mid Field Strength, High Field Strength; By Application: Brain and neurological, Spine and musculoskeletal, Vascular, Abdominal, Cardiac, Breast; By End-use: Hospitals, Imaging Centers, Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...